Apr 10, 2014
Painful side effect: Jobs could be slashed after Sun Pharma-Ranbaxy acquisitionThe Sun Pharma - Ranbaxy merger tops the list of some of the most interesting deals that the pharma space has seen in the last decade but will this $4 billion merger also be accompanied by job cuts in Ranbaxy?
Jan 25, 2014
Ranbaxy hit by FDA product ban at 4th Indian plantWASHINGTON/MUMBAI (Reuters) - Drugmaker Ranbaxy Laboratories Ltd( RANB.NS ) faces long delays and high costs in launching big-selling generic drugs in the United States after products from a fourth plant were banned from entering its main market due to manufacturing violations. The U.S. Food and Drug Administration's sanction is the latest in a series of regulatory rebukes for India's largest drugmaker by revenue since Japan's Daiichi Sankyo Co Ltd ( 4568.T ) took control of the company in 2008, and deals a further blow to the $12 billion Indian drug industry
Sep 17, 2013
Ranbaxy recovers after biggest single-day fall : All you need to knowA third Ranbaxy Laboratories Ltd plant in India has been hit by a US import ban over quality concerns, dealing a blow to the company's turnaround plans and threatening to hurt new launches and sales of medicines to its largest market.
Mar 16, 2012
Common medicines may cut cancer drug potency: studyMany patients taking a widely prescribed class of oral cancer drugs are also using a variety of medications that could reduce the effectiveness of the cancer treatment or increase its toxic side effects.
Jan 27, 2012
US agencies knock bottom out of Ranbaxy's future blockbustersRanbaxy's future blockbuster drugs may have been compromised by a settlement with US prosecutors for sale of adulterated drugs